QUIA PHARMA ABQUIA PHARMA ABQUIA PHARMA AB

QUIA PHARMA AB

No trades
See on Supercharts
Market capitalization
‪21.60 M‬SEK
−0.0376SEK
‪−16.52 M‬SEK
0.00SEK
Beta (1Y)
−2.72
Employees (FY)
3
Change (1Y)
−1 −25.00%
Revenue / Employee (1Y)
0.00SEK
Net income / Employee (1Y)
‪−5.51 M‬SEK

About QUIA PHARMA AB


CEO
Hans Marcus Bosson
Headquarters
Uppsala
Founded
2004
ISIN
SE0020678159
FIGI
BBG001Y25R55
QUIA PHARMA AB engages in the research, development, and commercialization of drug delivery system. Its product, Uni-Qleaver®, uses releasable pegylation technology that eliminates potential drawbacks and adjusts the drug's half-life. The company was founded by Marek Kwiatkowski and is headquartered in Uppsala, Sweden.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of QUIA is 0.0145 SEK — it has decreased by −15.70% in the past 24 hours. Watch QUIA PHARMA AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange QUIA PHARMA AB stocks are traded under the ticker QUIA.
QUIA stock has fallen by −18.99% compared to the previous week, the month change is a −53.23% fall, over the last year QUIA PHARMA AB has showed a −79.17% decrease.
QUIA reached its all-time high on Nov 5, 2007 with the price of 2,500.0000 SEK, and its all-time low was 0.0120 SEK and was reached on Nov 25, 2024. View more price dynamics on QUIA chart.
See other stocks reaching their highest and lowest prices.
QUIA stock is 63.64% volatile and has beta coefficient of −2.72. Track QUIA PHARMA AB stock price on the chart and check out the list of the most volatile stocks — is QUIA PHARMA AB there?
Today QUIA PHARMA AB has the market capitalization of ‪21.60 M‬, it has increased by 1.14% over the last week.
Yes, you can track QUIA PHARMA AB financials in yearly and quarterly reports right on TradingView.
QUIA net income for the last half-year is ‪−7.17 M‬ SEK, while the previous report showed ‪−6.69 M‬ SEK of net income which accounts for −7.30% change. Track more QUIA PHARMA AB financial stats to get the full picture.
No, QUIA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 24, 2024, the company has 3.00 employees. See our rating of the largest employees — is QUIA PHARMA AB on this list?
Like other stocks, QUIA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade QUIA PHARMA AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So QUIA PHARMA AB technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating QUIA PHARMA AB stock shows the sell signal. See more of QUIA PHARMA AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.